Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Equity Brief: Ratings Changes for December 18th: HERO, HFC, HIBB, HMA, HPQ, HRZN, IDIX, IGT


Print article Print article
Copyright © Thomson Reuters 2012. All rights reserved.
2012-12-18 16:29:05 -

A number of stocks were upgraded and downgraded by equities research analysts
today, as reported by Analyst Ratings Network ( bit.ly/equitybriefdaily)
and Equity Brief:

Deutsche Bank reiterated its buy rating on shares of Hercules Offshore, Inc.
(HERO). They have a $5.00 price target on the stock, down previously from $8.00.

Oppenheimer raised its price target on shares of HollyFrontier Corp (HFC) from
$46.00 to $55.00. They have an outperform rating on the stock.

Feltl & Co. upgraded shares of Hibbett Sports, Inc. (HIBB) from a hold rating to
a buy rating. Feltl & Co. now has a $63.00 price target on the stock.

Robert W. Baird reiterated its neutral rating on shares of Health Management
Associates (HMA). They have a $10.00 price target on the stock, up previously
from $9.00.

JPMorgan Chase 
initiated coverage on shares of Health Management Associates (HMA). They issued a neutral rating on the stock. RBC Capital reiterated its sector perform rating on shares of Hewlett-Packard (HPQ). They have a $18.00 price target on the stock, up previously from $14.00. Topeka Capital downgraded shares of Hewlett-Packard (HPQ) from a hold rating to a sell rating. Their analysts now have a $11.50 price target on the stock. They wrote, "In less than a month, HP's stock has rallied 31% from the November 20th low to yesterday's intra-day high on what we believe is a combination of hope that a major shake up at HP is around the corner and short covering activity. Given the secular portfolio challenges we expect HP to face in the foreseeable future, combined with a soft spending environment, we believe investors should take advantage of this early holiday gift and take profits in the stock." Wells Fargo & Co. upgraded shares of Horizon Technology Finance (HRZN) from a market perform rating to an outperform rating. Deutsche Bank reiterated its rating on shares of Idenix Pharmaceuticals, Inc. (IDIX). They have a $7.00 price target on the stock. Deutsche Bank reiterated its buy rating on shares of International Game Technology (IGT). They have a $16.00 price target on the stock, down previously from $19.00. Robert W. Baird reiterated its neutral rating on shares of Illumina, Inc. (ILMN). They have a $54.00 price target on the stock. Stay on top of analysts' coverage with Analyst Ratings Network's free daily email newsletter that provides a concise list of analysts' upgrades, downgrades and initiations. Register at bit.ly/equitybriefdaily Content and Media Contact: newseditor@equitybrief.net This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Equity Brief via Thomson Reuters ONE [HUG#1666081]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser